Raising $200M & Building AI for Drug Discovery | BenchSci Co-founder and CEO, Liran Belenzon

Most people don’t realize how broken drug discovery really is. According to Liran Belenzon, companies can spend seven years and hundreds of millions of dollars on a drug candidate—only to see it fail in human trials.

In this episode, Liran explains why biology is one of the most complex systems humans have ever tried to understand and how AI can help researchers uncover patterns humans miss.

The discussion explores why even small improvements in success rates could completely reshape healthcare outcomes worldwide.

This episode is a powerful glimpse into the future of science and medicine.

Learn more about your ad choices. Visit megaphone.fm/adchoices